Position in RDY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$133,500,266
-$4,779,267 QoQ
Shares Held
9,213,269
-7.7% QoQ
Ownership
1.11%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#4
of 238 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RDY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026ROYAL BANK OF CANADA holds $624,876,780 across 66 Drug Manufacturers - Specialty & Generic names. RDY ranks #1 (21.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RDY |
Dr Reddys Laboratories Ltd
This page
|
9,213,269 | $133,500,266 | |
| 2 | ZTS |
Zoetis Inc.
|
1,828,326 | $131,383,499 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
583,476 | $98,339,041 | |
| 4 | BHC |
Bausch Health Companies Inc.
|
10,832,582 | $53,404,627 | |
| 5 | VTRS |
Viatris Inc
|
3,135,460 | $49,791,098 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
62,600 | $33,918,552 | |
| 7 | TEVA |
Teva Pharmaceutical Industries Ltd
|
953,413 | $32,301,629 | |
| 8 | HLN |
Haleon plc
|
3,385,489 | $31,586,609 |
All Filings in RDY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $133,500,266 | 9,213,269 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $138,279,533 | 9,984,082 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $134,071,848 | 9,549,277 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $142,067,764 | 10,162,215 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $149,729,580 | 9,962,048 | Shares | Defined | 2025-11-21 | |
| 2025-03-31 | $119,380,036 | 9,050,799 | Shares | Defined | 2025-11-21 | |
| 2024-12-31 | $158,488,112 | 10,037,246 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $158,509,343 | 1,995,083 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $156,613,343 | 2,055,563 | Shares | Defined | 2024-11-06 | |
| 2024-03-31 | $158,754,704 | 2,164,345 | Shares | Defined | 2024-11-05 | |
| 2023-12-31 | $154,454,167 | 2,219,807 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $143,591,017 | 2,147,316 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $182,146,312 | 2,886,172 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $166,534,822 | 2,925,256 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $152,547,095 | 2,947,770 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $160,219,541 | 3,061,130 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $179,125,442 | 3,233,895 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $187,335,391 | 3,361,482 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $223,559,277 | 3,417,815 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $218,698,885 | 3,357,367 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $245,046,170 | 3,333,508 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $207,521,034 | 3,380,372 | Shares | Defined | 2021-07-20 | |
| 2020-12-31 | $243,887,079 | 3,421,056 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $248,150,705 | 3,567,434 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $193,790,563 | 3,655,736 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $153,213,908 | 3,799,006 | Shares | Defined | 2020-06-16 | |
| No filing history on record for this holder in this stock. | ||||||